×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Levine Mark S.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerAug 21, 2024Sale$31.863,295104,976330,230Aug 23, 2024, 04:15 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerJul 24, 2024Sale$27.764,015111,456333,394Jul 26, 2024, 04:17 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerJul 17, 2024Sale$29.692,50574,382337,556Jul 19, 2024, 05:42 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerMay 22, 2024Sale$29.653,24296,125339,914May 24, 2024, 04:10 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerApr 24, 2024Sale$28.903,963114,531343,156Apr 26, 2024, 05:18 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerApr 17, 2024Sale$29.069,827285,554349,344Apr 19, 2024, 06:06 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerFeb 22, 2024Sale$36.152,13477,144301,968Feb 23, 2024, 04:18 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerJan 26, 2024Sale$37.923,027114,778304,148Jan 29, 2024, 04:12 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerNov 22, 2023Sale$32.783,252106,598307,253Nov 24, 2023, 02:41 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerOct 25, 2023Sale$34.664,107142,349310,381Oct 27, 2023, 04:04 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerAug 24, 2023Sale$20.3012,286249,406314,489Aug 25, 2023, 05:05 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerJul 26, 2023Sale$21.633,91784,725326,774Jul 27, 2023, 04:33 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerApr 25, 2023Sale$16.292,63342,892330,691Apr 26, 2023, 04:08 PM
IMVTImmunovant, Inc.Levine Mark S.Chief Legal OfficerJan 26, 2023Sale$18.5110,156187,988245,660Jan 27, 2023, 07:20 AM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselNov 19, 2021Option Exercise$8.50133,4861,134,6310Nov 19, 2021, 10:08 AM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJul 19, 2021Sale$6.453,94525,445133,486Jul 20, 2021, 08:45 PM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJan 05, 2021Sale$11.136,82976,007107,431Jan 07, 2021, 05:52 PM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJun 22, 2020Option Exercise$10.831,02311,07975,510Jun 24, 2020, 04:12 PM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJun 21, 2019Option Exercise$9.811,21311,90046,273Jun 24, 2019, 04:14 PM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJan 03, 2019Sale$12.367349,0729,060Jan 04, 2019, 05:12 PM
FLXNFlexion Therapeutics IncLevine Mark S.General CounselJun 20, 2018Option Exercise$21.2253911,4388,872Jun 22, 2018, 04:30 PM
NERVMinerva Neurosciences, Inc.Levine Mark S.SVP,General Counsel & Sec.Jun 01, 2017Sale$11.0017,500192,5000Jun 05, 2017, 04:33 PM
NERVMinerva Neurosciences, Inc.Levine Mark S.SVP,General Counsel & Sec.Jun 01, 2017Option Exercise$5.1917,50090,82517,500Jun 05, 2017, 04:33 PM
NERVMinerva Neurosciences, Inc.Levine Mark S.SVP,General Counsel & Sec.Jan 04, 2017Option Exercise$4.7217,50082,54517,500Jan 06, 2017, 04:28 PM
NERVMinerva Neurosciences, Inc.Levine Mark S.SVP,General Counsel & Sec.Jan 04, 2017Sale$12.0017,500210,0000Jan 06, 2017, 04:28 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe